10A N.C. Admin. Code 26F.0106

Current through Register Vol. 39, No. 9, November 1, 2024

Section 26F .0106 - SCHEDULE V

(a) Schedule V shall consist of the drugs and other substances by whatever official name, common or usual name, chemical name, or brand name designated and listed in either G.S. 90-93 or this Rule. Each drug or substance is set forth in this Rule with its corresponding Drug Enforcement Administration (DEA) controlled substances code number set forth in the Code of Federal Regulations, Title 21, Section 1308.l5.

(b) Narcotic drugs containing non-narcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth in this Paragraph, which shall include one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:

(1) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams,

(2) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams,

(3) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams,

(4) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit,

(5) not more than 100 milligrams of opium per 100 milliliters or per 100 grams,

(6) not more than 0.5 milligrams of difenoxin and not less than 25 micrograms atropine sulfate per dosage unit.

(c) Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers: Pyrovalerone - DEA controlled substances code number 1485.

(d) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

(1) Lacosamide - DEA controlled substances code number 2746;

(2) Ezogabine - DEA controlled substances number 2779;

(3) Cenobamate - DEA controlled substances number 2720; and

(4) Lasmiditan - DEA controlled substances number 2790.

10A N.C. Admin. Code 26F .0106

Authority G.S. 90-88; 90-93; 143B-147;
Eff. June 30, 1978;
Amended Eff. July 1, 2012; February 1, 2010; April 1, 1992; August 1, 1988; December 1, 1987; April 1, 1983;
Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. February 2, 2016;
Amended Eff. December 1, 2021; March 1, 2021; January 1, 2019.

Authority G.S. 90-88; 90-93; 143B-147;
Eff. June 30, 1978;
Amended Eff. July 1, 2012; February 1, 2010; April 1, 1992; August 1, 1988; December 1, 1987; April 1, 1983.

Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. February 2, 2016;
Amended by North Carolina Register Volume 33, Issue 15, February 1, 2019 effective 1/1/2019.

Amended by North Carolina Register Volume 35, Issue 19, April 1, 2021 effective 3/1/2021.

Amended by North Carolina Register Volume 36, Issue 13, January 3, 2022 effective 12/1/2021.